SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-21-000015
Filing Date
2021-02-25
Accepted
2021-02-25 08:00:41
Documents
16
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20210225.htm   iXBRL 8-K 41369
2 EX-99.1 goss-20210225xexx991.htm EX-99.1 65915
8 gossamer1.jpg GRAPHIC 2160
  Complete submission text file 0001728117-21-000015.txt   262920

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20210225.xsd EX-101.SCH 2432
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT goss-20210225_cal.xml EX-101.CAL 716
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT goss-20210225_def.xml EX-101.DEF 1649
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20210225_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20210225_pre.xml EX-101.PRE 13193
9 EXTRACTED XBRL INSTANCE DOCUMENT goss-20210225_htm.xml XML 10767
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 21676465
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences